# Jazz Pharmaceuticals Announces Third Quarter 2026 Financial Results

- Source: PR Newswire M&A
- Published: 2026-11-02T21:05:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-announces-third-quarter-2026-financial-results-302926800.html
- Canonical: https://groundlevelnews.com/story/jazz-pharmaceuticals-announces-third-quarter-2026-financial-results-e929a1/

– Broad commercial execution drives record quarterly revenues of $1.2 billion (+10% YoY) – – Company raises full year 2026 total revenue guidance – – Ziihera® launched in HER2+ 1L mGEA – – Xywav® revenues grew 12% YoY with 425 net patient adds in 3Q26 – – Closed Actio acquisition, adding...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._